Cargando…

Prognostic Impact of Direct (131)I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study

Background: Patients treated for intermediate- or high-risk differentiated thyroid carcinoma (DTC) and Thyroglobulin (TG) elevation during follow-up, require a diagnostic whole-body scan (DWBS) and if positive, (131)I treatment. This approach can lead to a delay in treatment and increased costs. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrillo, José F., Vázquez-Romo, Rafael, Ramírez-Ortega, Margarita C., Carrillo, Liliana C., Gómez-Argumosa, Edgar, Oñate-Ocaña, Luis F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828732/ https://www.ncbi.nlm.nih.gov/pubmed/31736875 http://dx.doi.org/10.3389/fendo.2019.00737

Ejemplares similares

Prediction of the recurrence probability in patients with parotid gland cancer
por: Vazquez-Romo, Rafael, et al.
Publicado: (2007)

Treatment of Unresectable Differentiated Thyroid Carcinoma With Upfront External Radiotherapy and Salvage Surgery: A STROBE-Compliant Retrospective Cohort Study
por: Carrillo, José F., et al.
Publicado: (2021)

Head-to-Head Comparison of (68)Ga-PSMA-11 and (131)I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent
por: Pitalua-Cortes, Quetzali, et al.
Publicado: (2021)

Editorial: Recent advances in papillary thyroid carcinoma: diagnosis and predictive factors
por: Volpi, Erivelto Martinho, et al.
Publicado: (2023)

Editorial: Recent advances in papillary thyroid carcinoma: Progression, treatment and survival predictors
por: Volpi, Erivelto Martinho, et al.
Publicado: (2023)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer
por: Yu, Feng, et al.
Publicado: (2021)

The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma
por: van der Boom, Trynke, et al.
Publicado: (2021)

Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma
por: Ma, Teng, et al.
Publicado: (2023)

A semiquantitative study of the optimal whole-body imaging time after (131)I therapy for differentiated thyroid cancer
por: Liu, Shuang, et al.
Publicado: (2022)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

Editorial: Recent advances in papillary thyroid carcinoma: Lymph node metastasis
por: Carrillo, Jose Federico, et al.
Publicado: (2022)

Analysis of factors influencing the clinical outcome after surgery and (131)I therapy in patients with moderate-risk thyroid papillary carcinoma
por: Li, Yixuan, et al.
Publicado: (2022)

Editorial: New strategies in treatment of differentiated thyroid carcinoma
por: Carrillo, Jose Federico, et al.
Publicado: (2022)

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
por: Klain, Michele, et al.
Publicado: (2019)

Cervical lymph node metastasis prediction of postoperative papillary thyroid carcinoma before (131)I therapy based on clinical and ultrasound characteristics
por: Yu, Fei, et al.
Publicado: (2023)

Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated (131)I therapy?
por: Jiang, Yongji, et al.
Publicado: (2023)

Clinical and Biochemical Characteristics of Severe Hypothyroidism Due to Autoimmune Thyroiditis in Children
por: Kucharska, Anna Małgorzata, et al.
Publicado: (2020)

Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of (131)I Therapy in Patients With Differentiated Thyroid Cancer Following Total Thyroidectomy: A Retrospective Study
por: Pan, Mengjiao, et al.
Publicado: (2022)

Post-surgical Thyroid Bed Pyoderma Gangrenosum Mimicking Recurrent Papillary Thyroid Carcinoma
por: Dolci, Alessia, et al.
Publicado: (2019)

Prediction of morbidity after gastrectomy for gastric adenocarcinoma using logistic regression analysis
por: Oñate-Ocaña, Luis F, et al.
Publicado: (2007)

Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
por: de Castro, Taciana Padilha, et al.
Publicado: (2019)

Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer
por: Gao, Haiyan, et al.
Publicado: (2023)

The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence
por: Jiang, Jie, et al.
Publicado: (2022)

Usefulness of second (131)I treatment in biochemical persistent differentiated thyroid cancer patients
por: Gambale, Carla, et al.
Publicado: (2023)

Prognostic significance of inflammatory markers LMR, PLR, MPV, FIB in intermediate-and high-risk papillary thyroid carcinoma
por: Li, Canxiao, et al.
Publicado: (2022)

Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status
por: Chen, Wen-Chieh, et al.
Publicado: (2022)

Clinical and biochemical determinants of length of stay, readmission and recurrence in patients admitted with diabetic ketoacidosis
por: Ata, Fateen, et al.
Publicado: (2023)

THU224 Is Chronic Lymphocytic Thyroiditis Associated With Aggressive Differentiated Thyroid Cancer In A Predominantly Hispanic Pediatric Population?
por: Solano, Natalia, et al.
Publicado: (2023)

Intraoperative Management of the Recurrent Laryngeal Nerve Transected or Invaded by Thyroid Cancer
por: Masuoka, Hiroo, et al.
Publicado: (2022)

Leukaemias and cancers following iodine-131 administration for thyroid cancer.
por: de Vathaire, F., et al.
Publicado: (1997)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer
por: Zhou, Ruo-Yun, et al.
Publicado: (2023)

Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment
por: Sa, Ri, et al.
Publicado: (2020)

The beneficial metabolic actions of prolactin
por: Macotela, Yazmín, et al.
Publicado: (2022)

Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
por: Wang, Bin, et al.
Publicado: (2023)

FRI131 Abrogation Of Transglutaminase 2 In Myeloid Cells Ameliorates Angiotensin II Induced Vascular Stiffness In Female Mice
por: Naz, Huma, et al.
Publicado: (2023)

Recurrent Concurrent Diabetic Ketoacidosis and Thyroid Storm
por: Crudo, David F, et al.
Publicado: (2021)

Features of Lymph Node Metastasis and Structural Recurrence in Papillary Thyroid Carcinoma Located in the Upper Portion of the Thyroid: A Retrospective Cohort Study
por: Heng, Yu, et al.
Publicado: (2022)

Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment
por: Zhang, Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oqd51drqf8j8rhtv3a3bih5nmr